Ashly E. Jordan

Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies

A Syndemic Model of Exchange Sex Among HIV-Positive Men Who Have Sex With Men

Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model

Non-alcoholic fatty liver disease – A global public health perspective

Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance

Burden of liver diseases in the world

A global view of hepatocellular carcinoma: trends, risk, prevention and management

Direct-acting antiviral agents for HCV infection affecting people who inject drugs

Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe

MSM starting preexposure prophylaxis are at risk of hepatitis C virus infection

Best Practices for Developing and Validating Scales for Health, Social, and Behavioral Research: A Primer

Early diagnosis and risk factors of acute hepatitis C in high-risk MSM on preexposure prophylaxis

Protective Immunity Against Hepatitis C: Many Shades of Gray

HCV epidemiology in high-risk groups and the risk of reinfection

Global burden of liver disease: 2023 update

Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviours among injecting partnerships

Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies

Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study

Chemsex and the city: sexualised substance use in gay bisexual and other men who have sex with men attending sexual health clinics

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Sexually Transmitted Infections Treatment Guidelines, 2021

Sexually transmitted hepatitis C infection: the evolving epidemic in HIV-positive and HIV-negative MSM

Sociodemographic risk factors for hepatitis C virus infection in a prospective cohort study of 257 persons in Canada who inject drugs

Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE‐C II study

Cost‐effectiveness of scaling‐up HCV prevention and treatment in the United States for people who inject drugs

IL-10 Synergizes with Multiple Cytokines in Enhancing HIV Production in Cells of Monocytic Lineage

A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1

Scaling‐up HCV prevention and treatment interventions in rural United States—model projections for tackling an increasing epidemic

Sexually transmitted hepatitis C virus infections: current trends, and recent advances in understanding the spread in men who have sex with men

The Effect of Female Sex on Hepatitis C Incidence Among People Who Inject Drugs: Results From the International Multicohort InC3 Collaborative

EASL Recommendations on Treatment of Hepatitis C 2018

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Global Elimination of Chronic Hepatitis

Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years

Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection

Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysis

Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men

The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions

Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006–2013

Hepatitis C virus infection among HIV-positive men who have sex with men: protocol for a systematic review and meta-analysis

Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis

An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential

Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs

Prevalence of hepatitis C virus infection among HIV+ men who have sex with men: a systematic review and meta-analysis

Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs